Bayer Stock Forecast for 2023 - 2025 - 2030
Updated on 05/21/2024
Bayer Stock Forecast and Price Target
According to four esteemed experts, the average price target for Bayer to reach this year is 30.00€, with a potential upside of approximately 4.64%. This prediction is based on a high estimate of 68.00€ and a low estimate of 25.00€. If you want to invest in BAYN stock, you might also want to take a look at how its competitors are doing.
4.64% Upside
Bayer Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Bayer's Price has decreased from 52.33€ to 0.00€ – a 100.00% drop. For next year, analysts predict Fair Value of 69.78€, which would mean an increase of 100.00%. Over the next seven years, experts predict that Bayer's Fair Value will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| LLY Stock Forecast | Eli Lilly and | Outperform |
16
|
$783.18 | Buy/Sell | $636.99 | 12.04% |
| COST Stock Forecast | Costco Wholesale | Outperform |
11
|
$793.00 | Buy/Sell | $696.20 | 1.39% |
| ABBV Stock Forecast | AbbVie | Outperform |
9
|
$164.56 | Buy/Sell | $178.42 | 10.90% |
| AZN Stock Forecast | AstraZeneca PLC | Outperform |
17
|
£120.96 | Buy/Sell | £165.99 | 34.80% |
| DHR Stock Forecast | Danaher | Outperform |
10
|
$267.11 | Buy/Sell | $260.33 | 1.99% |
Bayer Revenue Forecast for 2023 - 2025 - 2030
In the last three years, Bayer's Revenue has grown by 15.07%, rising from 41.40€B to 47.64€B. For next year, analysts predict Revenue of 50.31€B, which would mean an increase of 5.61%. Over the next seven years, experts predict that Bayer's Revenue will grow at a rate of 7.66%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ABT Stock Forecast | Abbott Laboratories | Outperform |
9
|
$103.21 | Buy/Sell | $118.92 | 22.57% |
| AMGN Stock Forecast | Amgen | Outperform |
4
|
$314.54 | Buy/Sell | $303.65 | 1.74% |
| DE Stock Forecast | Deere & | Outperform |
5
|
$391.48 | Buy/Sell | $424.33 | 9.58% |
.jpg)
Bayer Dividend per Share Forecast for 2023 - 2025 - 2030
In the last three years, Bayer's Dividend per Share has decreased by 94.50%, going from 2.00€ to 0.11€. For next year, analysts predict Dividend per Share of 2.54€, which would mean an increase of 2209.09%. Over the next seven years, experts predict that Bayer's Dividend per Share will grow at a rate of 2081.82%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| CSL Stock Forecast | CSL | Outperform |
12
|
$277.90 | Buy/Sell | $205.51 | -26.07% |
| BMY Stock Forecast | Bristol-Myers Squibb | Hold |
2
|
$43.36 | Buy/Sell | $58.15 | 24.54% |
| GILD Stock Forecast | Gilead Sciences Inc | Outperform |
11
|
$67.90 | Buy/Sell | $87.82 | 17.82% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| CL Stock Forecast | Colgate-Palmolive Co | Outperform |
18
|
$94.39 | Buy/Sell | $88.97 | 4.35% |
| BDX Stock Forecast | Becton Dickinson and Co | Outperform |
9
|
$237.13 | Buy/Sell | $284.47 | 18.08% |
| BAS Stock Forecast | BASF | Outperform |
12
|
49.26€ | Buy/Sell | 49.50€ | 13.68% |
Bayer EBITDA Forecast for 2023 - 2025 - 2030
Bayer's EBITDA has grown In the last three years, rising from 10.13€B to 11.33€B – a growth of 11.90%. In the next year, analysts believe that EBITDA will reach 13.61€B – an increase of 20.14%. For the next seven years, experts predict that Bayer's EBITDA will grow at a rate of 33.74%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| SGO Stock Forecast | Compagnie de Saint-Gobain | Outperform |
10
|
81.62€ | Buy/Sell | 69.97€ | 4.14% |
| ALC Stock Forecast | Alcon | Outperform |
8
|
CHF80.08 | Buy/Sell | CHF90.64 | 20.97% |
| GIVN Stock Forecast | Givaudan | Hold |
14
|
CHF4.18k | Buy/Sell | CHF3.14k | -7.89% |
Bayer EBIT Forecast for 2023 - 2025 - 2030
Bayer's EBIT has seen impressive growth In the last three years, rising from 7.07€B to 7.80€B – a growth of 10.34%. In the next year, analysts believe that EBIT will reach 9.30€B – an increase of 19.24%. For the next seven years, the forecast is for EBIT to grow by 41.44%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| DOW Stock Forecast | Dow | Hold |
2
|
$59.24 | Buy/Sell | $57.75 | 2.13% |
| CTVA Stock Forecast | Corteva | Outperform |
12
|
$56.74 | Buy/Sell | $61.72 | 14.56% |
| BEI Stock Forecast | Beiersdorf | Outperform |
17
|
145.35€ | Buy/Sell | 137.41€ | 2.51% |
Bayer EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Bayer's EPS has decreased from 6.39€ to 0.00€ – a 100.00% drop. For next year, analysts predict EPS of 8.52€, which would mean an increase of 100.00%. Over the next seven years, experts predict that Bayer's EPS will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BIIB Stock Forecast | Biogen | Outperform |
10
|
$231.58 | Buy/Sell | $299.62 | 24.58% |
| DD Stock Forecast | DuPont de Nemours | Outperform |
17
|
$79.87 | Buy/Sell | $75.38 | 3.92% |
| COLO B Stock Forecast | Coloplast A/S | Hold |
18
|
kr850.00 | Buy/Sell | kr812.28 | 5.88% |
.jpg)